The Department of Neurological Surgery at UCSF

Total Page:16

File Type:pdf, Size:1020Kb

The Department of Neurological Surgery at UCSF Year In Review 2010 The Department of Neurological Surgery at UCSF University of California San Francisco Neurological Surgery is a true example of how Contents technology will continue to improve our lives in the Brain Tumor Center 2 years to come. California Center Among the many honors for Pituitary Disorders 6 given to our faculty in 2010, I would like to recognize Brain & Spinal Injury Center 7 Dr. Nicholas Barbaro’s appointment as President of Adult Epilepsy Surgery 10 the Neurosurgical Society of America and Dr. Lawrence Epilepsy Research 11 Pitts’ appointment to Provost Movement Disorders and Executive Vice President Program 12 of Academic Affairs at the University of California, Vascular Neurosurgery Offi ce of the President. Program 16 I am exceedingly proud to have been chairman during Neurospinal Disorders a year marked by signifi cant Program 18 Letter from the Chair ingenuity and progress Pediatric towards understanding Since its inception in to train the future generation Neurological Surgery 22 and treating neurosurgical 1947, the Department of of academic neurosurgeons. disorders, and to work with Neurological Surgery at In this review, we highlight Pediatric Epilepsy Center 24 such a highly talented and UCSF has grown from a some of the major dedicated group of faculty UCSF Nerve Injury Clinic 24 division of the Department accomplishments and staff. of Surgery into one of the and fi ndings from the UCSF Neurological Surgery premier neurosurgical Department in 2010. Pain Management Program 24 programs in the world. In In one of the more exciting 2010, we have neurosurgery developments, this month Center for Neural Engineering services at all major hospitals we launched the Center & Prostheses 25 in the Bay Area and we were for Neural Engineering and again ranked in the top fi ve Prostheses (CNEP, page 25) neurosurgery programs on – a collaboration between US News & World Report’s UCSF and UC Berkeley. annual list of Best Hospitals. Mitchel S. Berger, Department of While bionics that meld mind We also ranked fi rst in MD, FACS, FAANS Neurological Surgery and machine have long been funding for neurosurgery the stuff of science fi ction, Kathleen M. Plant University of California, from the National Institutes this new program will build Distinguished Professor San Francisco of Health for the fi fth on current technologies that and Chairman consecutive year. Our central 505 Parnassus Ave., are already allowing patients mission is to give the best Department of Room 779 M to move artifi cial limbs with care possible to our patients; Neurological Surgery thought. By bridging the gap San Francisco, CA to improve therapies for between neuroscience and Director, UCSF 94143-0112 neurosurgical disorders; and Brain Tumor Center cognitive science, CNEP Phone: (415) 353-7500 Fax: (415) 353-2889 neurosurgery.ucsf.edu Design & layout: Victoria Maier Magbilang Illustration: Kenneth Xavier Probst Photography: Noah Berger, John Branscombe, Susan Merrell, Kaz Tsuruta The Brain Tumor Center at UCSF The Brain Tumor Center at UCSF is one of the largest and most comprehensive programs for brain tumor treatment in the United States. It includes the Division of Neuro-oncology, the Brain Tumor Research Center, and the Division of Translational Research. 2 Top: Susan Chang MD, Jennifer Clarke MD, Nicholas Butowski MD Bottom: 5-ALA causes tumor tissue to fl uoresce during surgery Clinical Trial Highlights in the United States as an will be to create a virtual • The UCSF Helen Diller investigational new drug at a tissue bank to prospectively Family Comprehensive • The Department of handful of select institutions, identify patient subgroups Cancer Center has been Neurological Surgery is and UCSF is the only who will be candidates for chosen as one of fi ve cancer participating in a Phase II institution on the West Coast clinical trials done at time of centers in the United States study of 5-aminolevulinic to offer this cutting-edge tumor recurrence. to participate in the Merck acid (5-ALA) to enhance neurosurgical treatment. Oncology Collaborative • The Department of visualization and resection Trials Network (OncoNet), a • The Ben and Catherine Ivy Neurological Surgery is of malignant brain tumors. global clinical trials network Foundation has funded a currently offering a Phase The prodrug 5-ALA taken focusing on the development new clinical trials consortium II clinical trial for a novel orally before surgery causes of Merck drug and of fi ve institutions across the vaccine to treat glioblastoma, fl uorescent porphyrins to vaccine candidates being United States, led by Michael led by Andrew Parsa accumulate in tumor tissue investigated for the treatment Prados MD, director of the MD, PhD. Once a tumor and can be visualized under and prevention of cancer, Division of Translational is removed, a vaccine fl uorescent light during including brain tumors. surgery to identify tumor Research. The main is created from proteins cells and facilitate a more objective of the consortium specifi c to that tumor and Collaboration provides complete resection. will be to perform small, a heat-shock protein, and funding for infrastructure, enriched-patient clinical trials injected back into the patient fast-track access to It has previously only been for recurrent glioblastoma. over time. This prepares the compounds and drugs for used outside the United The goals will be to screen immune system to produce clinical trials, and a scientifi c States, and the European promising molecularly T cells that fi nd and kill new educational exchange. Every data show that it improves targeted agents and to cancerous cells with proteins year, the network will enroll extent of resection and validate drug distribution, matching those extracted approximately 1,200 patients leads to longer progression- pharmacokinetics, and from the tumor. in 30 to 40 investigator- free survival for patients. pharmacodynamics in tumor initiated or company- 5-ALA is now being tested tissue. Another objective sponsored trials. Faculty Adult Clinical Oncolytic viral therapies; Nalin Gupta MD, PhD Russ Pieper PhD vascular biology of glioma Neuro-Oncology Pediatric brain tumors; Signal transduction; models cell-cell interactions of human gliomagenesis and Susan Chang MD Arturo Alvarez-Buylla PhD drug resistance Developmental neuroscience; Daphne Haas-Kogan MD Nicholas Butowski MD stem-cell neurobiology Apoptosis and genetic William Weiss MD, PhD Jennifer Clarke MD Krys Bankiewicz MD, PhD mutations; therapeutic Mouse models of irradiation enhancement human brain tumors Michael Prados MD Convection drug-delivery systems; gene therapy C. David James PhD Adult Brain Tumor John Wiencke PhD Surgery Mitchel S. Berger MD Molecular biology of CNS Biomarker development cancer; analysis of mutant and application in brain Brain mapping; molecular Mitchel S. Berger MD epidermal growth factor tumor etiology genetic basis, biology, and Manish Aghi MD receptors in malignant therapy of brain tumors gliomas; rodent model Margaret Wrensch Edward Chang MD MPH, PhD Gabriele Bergers PhD testing of experimental Sandeep Kunwar MD therapies Genetic and molecular Angiogenesis; epidemiology of adult glioma Michael McDermott MD tumor invasion Andrew Parsa MD, PhD Andrew Parsa MD, PhD Shichun Zheng PhD Soonmee Cha MD Immunotherapy Molecular neuroepidemiology Neuropsychology Perfusion magnetic Claudia Petritsch PhD resonance imaging Caroline Racine PhD Brain cancer stem cells; Joe Costello PhD asymmetric stem cell BTRC Laboratories division; novel tumor Functional genomics suppressor genes Manish Aghi MD, PhD UCSF Neuro-Oncologists and prognostic markers Several new research studies of convection Have Highest Patient and improving classifi cation projects were initiated in enhanced delivery into the Satisfaction Scores and grading schemes for 2010, while many of our program’s overall focus on brain tumors. Dr. Phillips ongoing investigations neuroimaging. The Neuro-Oncology also directs the Molecular yielded signifi cant results. Partnering with veterinarians Service was awarded the Morphology Laboratory, • California Institute for at UC Davis, P01 investigator UCSF Medical Center which is a core resource Regenerative Medicine Krystof Bankiewicz MD, PhD Pinnacle Award for the to assist investigators in (CIRM) Disease Team Award: used convection-enhanced third consecutive year. This optimizing techniques for Funded by a $19 million delivery of nanoliposomal award recognizes the UCSF immunohistochemistry, grant from CIRM, the BTRC CPT-11 to treat dogs with medical service with the best molecular in situ studies, and will lead studies with other spontaneous brain tumors, patient satisfaction scores for laser capture microdissection. outpatient care. California institutions to which are very similar to Brain Tumor genetically engineer stem tumors that arise in humans. Brain Tumor Center Research Center cells that deliver therapeutic CPT-11 was infused directly Welcomes New agents to selectively kill into the brain tumors via Neuropathologists Continuously funded by glioblastoma cells. If convection-enhanced grants from the National approved by the FDA, it will delivery, and its distribution Neuropathologists Joanna Institutes of Health (NIH) be tested fi rst in patients with was monitored in real time Phillips MD, PhD and Arie since 1972, the Brain Tumor recurrent glioblastoma. using intraoperative MRI. Perry MD have joined the Research Center (BTRC) Three years later, many of the • NIH Program Project Brain Tumor Center
Recommended publications
  • Ethics for Digital Journalists
    ETHICS FOR DIGITAL JOURNALISTS The rapid growth of online media has led to new complications in journalism ethics and practice. While traditional ethical principles may not fundamentally change when information is disseminated online, applying them across platforms has become more challenging as new kinds of interactions develop between jour- nalists and audiences. In Ethics for Digital Journalists , Lawrie Zion and David Craig draw together the international expertise and experience of journalists and scholars who have all been part of the process of shaping best practices in digital journalism. Drawing on contemporary events and controversies like the Boston Marathon bombing and the Arab Spring, the authors examine emerging best practices in everything from transparency and verifi cation to aggregation, collaboration, live blogging, tweet- ing, and the challenges of digital narratives. At a time when questions of ethics and practice are challenged and subject to intense debate, this book is designed to provide students and practitioners with the insights and skills to realize their potential as professionals. Lawrie Zion is an Associate Professor of Journalism at La Trobe University in Melbourne, Australia, and editor-in-chief of the online magazine upstart. He has worked as a broadcaster with the Australian Broadcasting Corporation and as a fi lm journalist for a range of print publications. He wrote and researched the 2007 documentary The Sounds of Aus , which tells the story of the Australian accent. David Craig is a Professor of Journalism and Associate Dean at the University of Oklahoma in the United States. A former newspaper copy editor, he is the author of Excellence in Online Journalism: Exploring Current Practices in an Evolving Environ- ment and The Ethics of the Story: Using Narrative Techniques Responsibly in Journalism .
    [Show full text]
  • Surgery Guidelines Infection Prevention
    SURGERY GUIDELINES SURGICAL SITE INFECTION: REDUCING YOUR RISK A surgical site infection is a Stanford Hospital & Clinics is committed to implementing strategies to improve risk with any type of surgery. surgical care and to reduce the risk of You can take steps to reduce surgical site infections. your risk of surgical site We want your surgical experience at Stanford Hospital & Clinics to be positive. infection and complications. That experience includes educational • Talk with your healthcare provider materials that describe the process of your about your risk of infection and review surgery and the measures we take to ensure your safety. It is especially important to steps you can take to reduce your reduce the risk of infection. risk prior to the procedure. These are general guidelines. You will • Know the signs and symptoms be provided with more specific instructions of surgical site infection. related to your surgery before your discharge from the hospital. • Know how to reduce your risk while you are in the hospital. INFECTION PREVENTION stanfordhospital.org stanfordhospital.org PRIOR TO DAY OF AFTER SURGERY SURGERY SURGERY KEY POINTS HEALTHCARE TEAMS’ ROLE IN PREVENTION After your surgery and hospital stay, it is Tell your healthcare provider about other • Your surgeon may use electric clippers to important to watch for any changes in your medical problems you may have. Factors remove some of your hair before surgery. symptoms. Call your physician immediately or such as diabetes, obesity, smoking and some • Your surgical team will apply a skin antiseptic go to the nearest emergency room if you are medications could affect your surgery and immediately before the surgery experiencing any of the following symptoms: your treatment.
    [Show full text]
  • 2002-03 Budget for Current Operations and Extramurally Funded Operations (Table)
    2002 2003 Budget for Current Operations UNIVERSITY OF CALIFORNIA Office of the President November 2001 The President’s Message Just one year ago, California enjoyed near-record prosperity and an optimistic view of its future. Today the state faces a major economic slowdown and the unresolved menace of international terrorism. The world has suddenly become a much less certain place for individuals and institutions alike. Yet if there is one thing the current climate of uncertainty and risk makes dramatically clear, it is that research universities are indispensable to solving the nation’s most pressing problems, especially the threats of the new world in which we find ourselves. University of California engineers are already at work on technology that will make future high-rise buildings less vulnerable to terrorist attacks. Experts in bioterrorism are exploring ways to detect toxic substances and remove them from our air and water. Specialists in cybersecurity are investigating threats to communications networks that might develop in the next five to ten years and countermeasures to defend those networks. This is in addition to the daily discoveries and innovations that help make California, in the words of Federal Reserve Chairman Alan Greenspan, “preeminent in transforming knowledge into economic value.” And this does not take into account the outstanding education we give our students across the UC System and the remarkable variety of public service we offer California’s citizens. Given the reality of the State’s fiscal situation, we will have difficult choices to make in the year ahead. But most economists believe that the major fiscal problems of the State are short-term in nature, a perspective that should guide our decision-making as we weigh priorities.
    [Show full text]
  • Medications to Avoid Before Surgery
    ENTRUST MEDICAL GROUP Pre‐operative Information Medications to Avoid Before Surgery It is important to avoid certain medications prior to surgery. The following medications can have effects on bleeding, swelling, increase the risk of blood clots, and cause other problems if taken around the time of surgery. Please notify your surgeon’s office if you are taking any vitamins, herbal medications/supplements as these can also cause problems during your surgery and should not be taken for the two week period before surgery and one week after surgery. It is extremely important that if you come down with a cold, fever, rash, or “any new” medical problem close to your surgery date, you should notify your surgeon’s office immediately. Section One: The following drugs contain aspirin and/or aspirin like effects that may affect your surgery (abnormal bleeding and bruising). These drugs should be avoided for at least two weeks prior to surgery. A.P.C. Doloprin Nuprin A.S.A. Easprin Orudis A.S.A. Enseals Ecotrin Pabalate‐SF Advil Emprin with Codeine Pamelor Aleve Endep Parnate Alka‐Seltzer Plus Equagesic Tablets Percodan Alka‐Seltzer Etrafon Pepto‐Bismol (all types) Anacin Excedrin Persantine Anaprox Feldene Phenteramine Ansaid Fiorinal Phenylbutzone Argesic Flagly Ponstel Arthritis pain formula Four Way Cold Tablets Propoxyphene Compound Arthritis strength Bufferin Gemnisyn Robaxisal Arthropan Liquid Gleprin Rufen AS.A. Goody’s S‐A‐C Ascriptin Ibuprofen (all types) Saleto Asperbuf Indocin Salocol Aspergum Indomethacin Sine‐Aid/Sine‐Off/Sinutab Aspirin (all brands) Lanorinal SK‐65 Compound Atromid Lioresal St. Joseph’s Cold Tab B.C.
    [Show full text]
  • Women's Experimental Autobiography from Counterculture Comics to Transmedia Storytelling: Staging Encounters Across Time, Space, and Medium
    Women's Experimental Autobiography from Counterculture Comics to Transmedia Storytelling: Staging Encounters Across Time, Space, and Medium Dissertation Presented in partial fulfillment of the requirement for the Degree Doctor of Philosophy in the Graduate School of Ohio State University Alexandra Mary Jenkins, M.A. Graduate Program in English The Ohio State University 2014 Dissertation Committee: Jared Gardner, Advisor Sean O’Sullivan Robyn Warhol Copyright by Alexandra Mary Jenkins 2014 Abstract Feminist activism in the United States and Europe during the 1960s and 1970s harnessed radical social thought and used innovative expressive forms in order to disrupt the “grand perspective” espoused by men in every field (Adorno 206). Feminist student activists often put their own female bodies on display to disrupt the disembodied “objective” thinking that still seemed to dominate the academy. The philosopher Theodor Adorno responded to one such action, the “bared breasts incident,” carried out by his radical students in Germany in 1969, in an essay, “Marginalia to Theory and Praxis.” In that essay, he defends himself against the students’ claim that he proved his lack of relevance to contemporary students when he failed to respond to the spectacle of their liberated bodies. He acknowledged that the protest movements seemed to offer thoughtful people a way “out of their self-isolation,” but ultimately, to replace philosophy with bodily spectacle would mean to miss the “infinitely progressive aspect of the separation of theory and praxis” (259, 266). Lisa Yun Lee argues that this separation continues to animate contemporary feminist debates, and that it is worth returning to Adorno’s reasoning, if we wish to understand women’s particular modes of theoretical ii insight in conversation with “grand perspectives” on cultural theory in the twenty-first century.
    [Show full text]
  • UCSF Fact Sheet
    About UCSF University of California, San Francisco is the leading university exclusively focused on health. Through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in care delivery, UCSF is leading revolutions in health worldwide. UCSF Health was one of the first U.S. hospitals to provide care for patients with COVID-19 and played a significant role in the public health response in collaboration with the City and State, as well as in research into testing, transmission prevention and care protocols and working in our communities throughout the pandemic. UCSF Chancellor Health Care Sam Hawgood, MBBS, a renowned Q UCSF Health is recognized worldwide researcher, professor, academic leader for its innovative, patient-centered care, and pediatrician, has been Chancellor informed by pioneering research and of UCSF since 2014. advanced technologies. Recognized for his strong leadership as UCSF Medical Center ranks among the top 10 hospitals nationwide dean of UCSF School of Medicine from for the care it provides and is among the leading medical centers 2009 to 2014 and brief tenure as interim across all 15 specialties ranked by U.S. News & World Report. It is Chancellor, Hawgood was selected renowned for innovative care in cancer, neurology and neurosurgery, after a national search as UCSF’s 10th cardiology and cardiac surgery, otolaryngology, transplant, chancellor. He reports to UC President .JDIBFM7%SBLF .% and ophthalmology, pulmonology, and urology, among others. UIFUC Board of Regents. With more than 1,700 clinical trials each year, UCSF Health is at Today, Hawgood, the Arthur and Toni Rembe Rock Distinguished the forefront in offering patients the latest therapies, led by clinician Professor at UCSF, oversees a UCSF enterprise, which # researchers who are committed to providing the most advanced care includes the top public recipient of research funds from the in their fields.
    [Show full text]
  • Organ Transplant Discrimination Against People with Disabilities Part of the Bioethics and Disability Series
    Organ Transplant Discrimination Against People with Disabilities Part of the Bioethics and Disability Series National Council on Disability September 25, 2019 National Council on Disability (NCD) 1331 F Street NW, Suite 850 Washington, DC 20004 Organ Transplant Discrimination Against People with Disabilities: Part of the Bioethics and Disability Series National Council on Disability, September 25, 2019 This report is also available in alternative formats. Please visit the National Council on Disability (NCD) website (www.ncd.gov) or contact NCD to request an alternative format using the following information: [email protected] Email 202-272-2004 Voice 202-272-2022 Fax The views contained in this report do not necessarily represent those of the Administration, as this and all NCD documents are not subject to the A-19 Executive Branch review process. National Council on Disability An independent federal agency making recommendations to the President and Congress to enhance the quality of life for all Americans with disabilities and their families. Letter of Transmittal September 25, 2019 The President The White House Washington, DC 20500 Dear Mr. President, On behalf of the National Council on Disability (NCD), I am pleased to submit Organ Transplants and Discrimination Against People with Disabilities, part of a five-report series on the intersection of disability and bioethics. This report, and the others in the series, focuses on how the historical and continued devaluation of the lives of people with disabilities by the medical community, legislators, researchers, and even health economists, perpetuates unequal access to medical care, including life- saving care. Organ transplants save lives. But for far too long, people with disabilities have been denied organ transplants as a result of unfounded assumptions about their quality of life and misconceptions about their ability to comply with post-operative care.
    [Show full text]
  • Medical Centers Report
    Attachment 5 Medical Centers Report 18/19 UC Health is committed to nothing less than the well-being of all Californians. As one of the nation’s largest academic health systems, we combine teaching, research and public service to provide high quality care to millions of patients each year and to drive the medical advances that save lives. UNIVERSITY OF CALIFORNIA Medical Centers 18/19 Annual Financial Report TABLE OF CONTENTS 3 Letter from the Executive Vice President Medical Centers 4 The University of California, Davis Medical Center 8 The University of California, Irvine Medical Center 12 The University of California, Los Angeles Medical Center 16 The University of California, San Diego Medical Center 20 The University of California, San Francisco Medical Center and Children’s Hospital and Research Center Oakland 26 Management’s Discussion and Analysis 52 Report of Independent Auditors Financial Statements, University of California Medical Centers 54 Statements of Net Position 56 Statements of Revenues, Expenses and Changes in Net Position 58 Statements of Cash Flows 62 Notes to Financial Statements 110 Required Supplementary Information 116 University of California Regents and Officers 2 Letter from the Executive Vice President This is my last annual report letter as Executive Vice President • Our payor mix demonstrates our unwavering commitment of UC Health. to caring for all Californians regardless of ability to pay. Despite representing less than six percent of the acute After 50 years in Medicine and 11 years with the University care hospital beds in California, we are one of the largest of California, it is time for me to turn the reins of leadership for providers of inpatient services and hospital-based outpatient UC Health to another.
    [Show full text]
  • Phone Directory
    Phone Directory MAIN PHONE NUMBERS UCSF Medical Center at Mission Bay . (415)353-3000 UCSF Medical Center at Mount Zion . .(415) 567-6600 UCSF Medical Center at Parnassus . (415)476-1000 LOCATION KEY GMB UCSF Ron Conway Family Gateway Medical Building WCH UCSF Betty Irene Moore Women’s Hospital and UCSF Bakar Cancer Hospital BCH UCSF Benioff Children’s Hospital DEPARTMENT . LOCATION . PHONE* Admitting - Adult . WCH 1.476-1099 Blood Bank . .GMB 2.476-1404 Case Management - Adult (Main offi ce) . 514-3742 Case Management - Children’s (Main offi ce) . .353-2278 Central Patient Placement - Adult . .353-1937 Child Life Services (Main offi ce) . BCH 5 & 6 . .353-1203 Child Life Manager . .353-8500 Marie Wattis School Program . BCH 6 . 353-1310 Child Life Playground . BCH 5 . .353-1221 Center for Families . BCH 6 .353-1410 Clinical Lab . GMB2.353-1667 Blood Gas . .514-2146 Gift Shop . .BCH1476-1150 Infection Control . .353-4343 Interpreting Services . .GMB 1 .353-2690 IP3 . .WCH4353-1328 Information Desk - Adult . WCH 1 . .476-1540 Neurodiagnostics . BCH 5 .514-4177 Nursing Administration . BCH 1 . .476-1592 Nutrition and Food Services . WCH 1 . .476-1085 Room Service . .353-1111 *All phone numbers are in area code 415 DEPARTMENT ......................... LOCATION .... PHONE* Occupational Health & Safety . BCH 1 . 885-7580 Needlestick Exposure 24 Hour Number . .353-STIC (7842) Parking and Transportation . 476-1511 Pathology . GMB 2 . 353-1613 Patient Relations . BCH 1 . 353-1936 Patient Access - Children’s . BCH 1 . 353-1611 Pediatric Echocardiography . GMB 6 . 476-3774 Pediatric Pulmonary Function Lab . GMB 6 . 476-3774 Pediatric Stress Lab/EKG .
    [Show full text]
  • Medical Terminology Abbreviations Medical Terminology Abbreviations
    34 MEDICAL TERMINOLOGY ABBREVIATIONS MEDICAL TERMINOLOGY ABBREVIATIONS The following list contains some of the most common abbreviations found in medical records. Please note that in medical terminology, the capitalization of letters bears significance as to the meaning of certain terms, and is often used to distinguish terms with similar acronyms. @—at A & P—anatomy and physiology ab—abortion abd—abdominal ABG—arterial blood gas a.c.—before meals ac & cl—acetest and clinitest ACLS—advanced cardiac life support AD—right ear ADL—activities of daily living ad lib—as desired adm—admission afeb—afebrile, no fever AFB—acid-fast bacillus AKA—above the knee alb—albumin alt dieb—alternate days (every other day) am—morning AMA—against medical advice amal—amalgam amb—ambulate, walk AMI—acute myocardial infarction amt—amount ANS—automatic nervous system ant—anterior AOx3—alert and oriented to person, time, and place Ap—apical AP—apical pulse approx—approximately aq—aqueous ARDS—acute respiratory distress syndrome AS—left ear ASA—aspirin asap (ASAP)—as soon as possible as tol—as tolerated ATD—admission, transfer, discharge AU—both ears Ax—axillary BE—barium enema bid—twice a day bil, bilateral—both sides BK—below knee BKA—below the knee amputation bl—blood bl wk—blood work BLS—basic life support BM—bowel movement BOW—bag of waters B/P—blood pressure bpm—beats per minute BR—bed rest MEDICAL TERMINOLOGY ABBREVIATIONS 35 BRP—bathroom privileges BS—breath sounds BSI—body substance isolation BSO—bilateral salpingo-oophorectomy BUN—blood, urea, nitrogen
    [Show full text]
  • Regulation 4 —Pharmacy
    Agency # 070.00 REGULATION 4 —PHARMACY 04-00: GENERAL REGULATIONS REGARDING PHARMACIES 04-00-0001—EQUIPMENT SPECIFICATIONS Prescription equipment appropriate for the pharmacy’s specific scope of practice shall be maintained by the pharmacy and may include but is not limited to: (a) Graduates capable of measuring from 0.1ml to at least 120ml (b) Mortars and pestles--at least one (porcelain or glass) (c) Hot and cold running water in the prescription department (d) Spatulas (e) Ointment slab or ointment papers (f) Exempt narcotic record book (g) Class III balance and weights or comparable electronic scale (h) Equipment for labeling (i) Refrigeration for the proper storage of biologicals and other medications. Medications shall be stored in a separate compartment or area from food. Each pharmacy shall maintain a pharmacy library: (1) available for use by the pharmacist and the patient, including either current drug information manuals, or computers capable of printing current drug information for the pharmacist and patient drug information and monographs for patients. (2) other pharmacy reference books and periodicals necessary for effective pharmacy practice. EXCEPTIONS: Pharmacies meeting the requirements of regulation 04-02-0100 or regulation 07-02-0001 shall be exempt from requirements of this regulation when not applicable. (10/09/80, Revised 6/25/83, 4/07/89, 6/07/90, 8/20/97, 11/1/2007 and 11/6/2008) 04-00-0002—TIME REQUIRMENTS FOR PHARMACIES AND FOR THE PHARMACIST IN CHARGE (a) Unless expressly provided otherwise in Board regulations, all pharmacies in Arkansas shall be open a minimum of forty (40) hours per week and have on duty an Arkansas licensed pharmacist in charge.
    [Show full text]
  • Neuroplasticity in Adult Human Visual Cortex
    Neuroplasticity in adult human visual cortex Elisa Castaldi1, Claudia Lunghi2 and Maria Concetta Morrone3,4 1 Department of Neuroscience, Psychology, Pharmacology and Child health, University of Florence, Florence, Italy 2 Laboratoire des systèmes perceptifs, Département d’études cognitives, École normale supérieure, PSL University, CNRS, 75005 Paris, France 3 Department of Translational Research and New technologies in Medicine and Surgery, University of Pisa, Pisa, Italy 4 IRCCS Stella Maris, Calambrone (Pisa), Italy Abstract Between 1-5:100 people worldwide has never experienced normotypic vision due to a condition called amblyopia, and about 1:4000 suffer from inherited retinal dystrophies that progressively lead them to blindness. While a wide range of technologies and therapies are being developed to restore vision, a fundamental question still remains unanswered: would the adult visual brain retain a sufficient plastic potential to learn how to ‘see’ after a prolonged period of abnormal visual experience? In this review we summarize studies showing that the visual brain of sighted adults retains a type of developmental plasticity, called homeostatic plasticity, and this property has been recently exploited successfully for adult amblyopia recover. Next, we discuss how the brain circuits reorganizes when visual stimulation is partially restored by means of a ‘bionic eye’ in late blinds with Retinitis Pigmentosa. The primary visual cortex in these patients slowly became activated by the artificial visual stimulation, indicating that
    [Show full text]